# CTDSP2

## Overview
CTDSP2 (C-terminal domain small phosphatase 2) is a gene that encodes a protein belonging to the C-class phosphatase family, which plays a pivotal role in the regulation of transcription by dephosphorylating the C-terminal domain of RNA polymerase II. This enzymatic activity is essential for modulating the transition from transcription initiation to elongation, thereby influencing gene expression (Shi2021Wholeexome). The CTDSP2 protein is predominantly active in the nucleus and is involved in critical cellular processes such as cell cycle progression and differentiation. It is regulated by FOXO transcription factors and is implicated in various signaling pathways, including those that control cell cycle arrest and neuronal differentiation (Kloet2015FOXO; Han2012The). Additionally, CTDSP2 has been associated with certain cancers, such as clear cell renal cell carcinoma, where its expression levels may impact tumor progression and patient prognosis (Krasnov2023Tumor).

## Function
CTDSP2 (C-terminal domain small phosphatase 2) is a gene that encodes a protein involved in the regulation of RNA polymerase II by dephosphorylating its C-terminal domain (CTD). This activity is crucial for transcriptional regulation, influencing the transition from initiation to elongation during gene expression (Shi2021Wholeexome). CTDSP2 is active in the nucleus and plays a significant role in cell cycle progression and differentiation.

In healthy human cells, CTDSP2 is a target gene regulated by FOXO transcription factors, which are inhibited by growth factor-PI3K-PKB/Akt signaling. It is involved in cell cycle progression and can induce cell cycle arrest by up-regulating the CDK inhibitor p21 Cip1/Waf1, leading to decreased cyclin-CDK activity (Kloet2015FOXO). CTDSP2 also increases Ras activity, which further induces p21 Cip1/Waf1 through both p53-dependent and independent pathways (Kloet2015FOXO).

CTDSP2 expression leads to the down-regulation of E2F1 and cyclin E2, crucial for S-phase entry, while up-regulating E2F7, affecting the G1-to-S transition (Kloet2015FOXO). These molecular activities highlight CTDSP2's role in controlling cell cycle progression and its broader involvement in cellular processes regulated by FOXO proteins.

## Clinical Significance
CTDSP2 (CTD small phosphatase 2) has been implicated in various diseases through alterations in its expression levels and potential mutations. In clear cell renal cell carcinoma (ccRCC), CTDSP2 expression is decreased in the more aggressive ccB subtype, which is associated with poorer survival outcomes. This suggests a role in tumor progression and prognosis, although CTDSP2 did not exhibit tumor-suppressive effects in certain ccRCC cell line models (Krasnov2023Tumor). The study also noted that low expression levels of CTDSP2, along with other related phosphatases, correlate with worse overall survival in ccRCC patients (Krasnov2023Tumor).

In carotid body tumors (CBTs), CTDSP2 was identified as one of the genes with a high number of somatic mutations, although the clinical significance of these mutations remains unclear (Snezhkina2018Exome). Despite its involvement in these conditions, there is no direct evidence linking CTDSP2 mutations to specific congenital disorders or other diseases in the provided context. The complexity of its role in cancer and other diseases highlights the need for further research to fully understand its clinical implications.

## Interactions
CTDSP2, a C-class phosphatase, is involved in several interactions that regulate neuronal differentiation and neural progenitor development. It interacts with the REST complex, a transcriptional regulator that represses neuronal gene expression. This interaction is crucial for REST function, and the knockdown of CTDSP2 induces neuronal differentiation (Han2012The). CTDSP2 is also co-expressed with the microRNA miR-26b, which regulates its expression post-transcriptionally. miR-26b targets CTDSP2 mRNA, leading to its repression, which is significant during neuronal differentiation (Han2012The).

In the context of neural progenitor development, CTDSP2 is involved in a regulatory loop with miR-26 and the target gene Emx2. miR-26a, co-expressed with CTDSP2, promotes neural progenitor proliferation by controlling cell-cycle progression. Emx2, which limits neural progenitor expansion, is targeted by miR-26a, suggesting a cohesive regulatory mechanism involving CTDSP2, miR-26, and Emx2 (Zhang2018Cohesive).

The interactions of CTDSP2 with other proteins or nucleic acids in humans are not explicitly detailed in the provided context, but its role in transcriptional regulation and potential involvement in multiprotein complexes is implied (Han2012The).


## References


[1. (Shi2021Wholeexome) Lili Shi, Ming Li, Hong Qi, Jianjiang Zhu, Jing Yang, Jie Tang, and Longxia Wang. Whole-exome sequencing analysis to identify novel potential pathogenetic mutations in fetuses with abnormal brain structure. Annals of Translational Medicine, 9(9):807–807, May 2021. URL: http://dx.doi.org/10.21037/atm-21-1477, doi:10.21037/atm-21-1477. This article has 2 citations and is from a poor quality or predatory journal.](https://doi.org/10.21037/atm-21-1477)

[2. (Snezhkina2018Exome) Anastasiya V. Snezhkina, Elena N. Lukyanova, Dmitry V. Kalinin, Anatoly V. Pokrovsky, Alexey A. Dmitriev, Nadezhda V. Koroban, Elena A. Pudova, Maria S. Fedorova, Nadezhda N. Volchenko, Oleg A. Stepanov, Ekaterina A. Zhevelyuk, Sergey L. Kharitonov, Anastasiya V. Lipatova, Ivan S. Abramov, Alexander V. Golovyuk, Yegor E. Yegorov, Khava S. Vishnyakova, Alexey A. Moskalev, George S. Krasnov, Nataliya V. Melnikova, Dmitry S. Shcherbo, Marina V. Kiseleva, Andrey D. Kaprin, Boris Y. Alekseev, Andrew R. Zaretsky, and Anna V. Kudryavtseva. Exome analysis of carotid body tumor. BMC Medical Genomics, February 2018. URL: http://dx.doi.org/10.1186/s12920-018-0327-0, doi:10.1186/s12920-018-0327-0. This article has 19 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/s12920-018-0327-0)

[3. (Han2012The) Jinju Han, Ahmet M. Denli, and Fred H. Gage. The enemy within: intronic mir-26b represses its host gene,ctdsp2, to regulate neurogenesis. Genes &amp; Development, 26(1):6–10, January 2012. URL: http://dx.doi.org/10.1101/gad.184416.111, doi:10.1101/gad.184416.111. This article has 30 citations.](https://doi.org/10.1101/gad.184416.111)

[4. (Zhang2018Cohesive) Haijun Zhang, Longbin Zhang, and Tao Sun. Cohesive regulation of neural progenitor development by microrna mir-26, its host gene ctdsp and target gene emx2 in the mouse embryonic cerebral cortex. Frontiers in Molecular Neuroscience, February 2018. URL: http://dx.doi.org/10.3389/fnmol.2018.00044, doi:10.3389/fnmol.2018.00044. This article has 15 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fnmol.2018.00044)

[5. (Krasnov2023Tumor) George S. Krasnov, Grigory A. Puzanov, Erdem B. Dashinimaev, Khava S. Vishnyakova, Tatiana T. Kondratieva, Yegor S. Chegodaev, Anton Y. Postnov, Vera N. Senchenko, and Yegor E. Yegorov. Tumor suppressor properties of small c-terminal domain phosphatases in clear cell renal cell carcinoma. International Journal of Molecular Sciences, 24(16):12986, August 2023. URL: http://dx.doi.org/10.3390/ijms241612986, doi:10.3390/ijms241612986. This article has 2 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/ijms241612986)

[6. (Kloet2015FOXO) David E.A. Kloet, Paulien E. Polderman, Astrid Eijkelenboom, Lydia M. Smits, Miranda H. van Triest, Maaike C.W. van den Berg, Marian J. Groot Koerkamp, Dik van Leenen, Philip Lijnzaad, Frank C. Holstege, and Boudewijn M.T. Burgering. Foxo target gene ctdsp2 regulates cell cycle progression through ras and p21cip1/waf1. Biochemical Journal, 469(2):289–298, July 2015. URL: http://dx.doi.org/10.1042/bj20140831, doi:10.1042/bj20140831. This article has 23 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1042/bj20140831)